Actually, 2 respected posters, Dew Diligence (GENR IHUB)and Eventhorzg (on CNVX Yahoo board)are still very bullish on OSIP, despite the run-up. They feel there is yet more upside for this behemoth for the following reasons: *Europe and Japan approval for Tarceva pending; *Pricing of Tarceva at 2000/treatment way low and now with Iressa all but gone could be jacked up; *Theres a real possibility that DNA will gobble up OSIP.
Because of these pursuasive arguments I have taken up a position in the Jan. 65 calls. Merry Christmas DC and all.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.